A carregar...
Utility of BRAF VE1 Immunohistochemistry as a Screening Tool for Colorectal Cancer Harboring BRAF V600E Mutation
BACKGROUND: BRAF mutation has been recognized as an important biomarker of colorectal cancer (CRC) for targeted therapy and prognosis prediction. However, sequencing for every CRC case is not cost-effective. An antibody specific for BRAF V600E mutant protein has been introduced, and we thus examined...
Na minha lista:
| Publicado no: | J Pathol Transl Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5964290/ https://ncbi.nlm.nih.gov/pubmed/29590746 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4132/jptm.2018.03.28 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|